Clinical Trials Directory

Trials / Completed

CompletedNCT02485275

Stroke Imaging Package Study

Status
Completed
Phase
Study type
Observational
Enrollment
949 (actual)
Sponsor
Wei-Hai Xu · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.

Detailed description

1. Patients with acute ischemic stroke within 4.5-72h after onset were prospectively enrolled in our study and underwent standardized clinical and new imaging technique package assessment. 2. New imaging technique package mainly includes conventional cranial MRI (T1,T2,T2 FLAIR,DWI, and ADC), cranial magnetic resonance angiography (MRA), and intracranial vessel wall imaging (High-Resolution Magnetic Resonance Imaging,HRMRI) as well as susceptibility weighted imaging (SWI). 3. The neurofunctional fluctuation during hospitalization as well as 90-day outcomes were carefully assessed. Patients were followed up for 90-days after stroke onset. 4. Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.

Conditions

Timeline

Start date
2015-07-01
Primary completion
2017-04-30
Completion
2017-11-30
First posted
2015-06-30
Last updated
2018-12-14

Locations

16 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02485275. Inclusion in this directory is not an endorsement.